ArticleKidney international reports2026
Longitudinal Trajectories of CKD-Associated Pruritus.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chronic Pruritus in Predialysis Chronic Kidney Disease: Prevalence, Phenotype and Temporal Patterns in a Prospective Cohort.Acta dermato-venereologica · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Chronic kidney disease (CKD)-associated pruritus (CKD-aP) is a common and distressing symptom among dialysis patients, negatively affecting patient-reported outcomes (PROs) such as sleep and mental health. Despite its high prevalence, the evolution, incidence, and long-term impact of CKD-aP remains poorly understood. This study examined the cumulative incidence of new-onset CKD-aP among patients on hemodialysis (HD), identified its key predictors, and assessed associations between CKD-aP severity and PROs. Methods: In this prospective, multicenter cohort study, incident and prevalent HD patients from 6 European countries were followed over 18 months, with assessments every 3 months. Patients completed an electronic PRO (ePRO) survey, including the Kidney Disease Quality of Life Short Form 36-Item short-form survey itchy skin item and measures of fatigue, sleep, depression, and general health. Sankey diagrams and Spearman's correlations were used to describe pruritus evolution. Cox and linear regression models were used to identify predictors of moderate-to-severe pruritus and examined associations with PROs. Results: Among 747 patients, the 18-month cumulative incidence of moderate-to-severe pruritus was 52%. Baseline-to-follow-up correlations for pruritus severity declined over time, though short-term correlations remained strong. Sociodemographic and clinical characteristics were minimally predictive of incident pruritus. Compared with those without pruritus, patients with incident pruritus reported higher fatigue (+0.7 [0.1-1.4]) and lower sleep quality scores (-1.0 [-1.6 to -0.5]). Similar patterns were observed for persistent versus resolved pruritus. Conclusion: CKD-aP is a prevalent and fluctuating symptom in patients on HD. Its association with poorer fatigue and sleep outcomes highlights the importance of ongoing monitoring and targeted management to improve patient well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.